Revista nº 815

Casas-Maldonado, F | Tratamiento y prevención de COVID-19 49 Actual Med.2022;107(815):39- 50 22. Bernheim A, Mei X, Huang M, et al. Chest CT. fin- dings in coronavirus disease 2019 (COVID-19): Re- lationship to duration of infection. Radiology. 2020 Jun;295(3):200463. DOI: 10.1148/radiol.2020200463 23. Wilkinson T, Dixon R, Page C, et al. ACCORD: a multicen- tre, seamless, phase 2 adaptive randomisation platform study to assess the efficacy and safety of multiple can- didate agents for the treatment of COVID-19 in hospi- talised patients: a structured summary of a study pro- tocol for a randomised controlled trial. Trials. 2020 Jul 31;21(1):691. DOI: 10.1186/s13063-020-04584-9 24. Paumgartten FJR, de Oliveira ACAX. Off label, com- passionate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues. Cien Saude Colet. 2020 Sep;25(9):3413-3419. DOI: 10.1590/1413-81232020259.16792020 25. Modificada de: Chalmers JD, Crichton ML, Goeminne PC, et al. Management of hospitalised adults with co- ronavirus disease 2019 (COVID-19): a European Respi- ratory Society living guideline. Eur Respir J. 2021 Apr 15;57(4):2100048. DOI: 10.1183/13993003.00048-2021 26. Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wa- jnberg A, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020 Sep;8(9):e70. DOI: 10.1016/S2213-2600(20)30354-4 27. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020 May 22;369:m1966. DOI: 10.1136/bmj.m1966 28. Knight SR, Ho A, Pius R, et al. Risk stratification of pa- tients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: develo- pment and validation of the 4C Mortality Score. BMJ. 2020 Sep 9;370:m3339. DOI: 10.1136/bmj.m3339 29. Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS- CoV-2: a prospective cohort study. Eur Respir J. 2020 Sep 24;56(3):2050524. DOI: 10.1183/13993003.50524- 2020 30. Chen N, Zhou M, Dong X, et al. Epidemiological and cli- nical characteristics of 99 cases of 2019 novel corona- virus pneumonia in Wuhan. China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. DOI: 10.5271/ sjweh.3960 31. Wei J, Yang H, Lei P, Fan B, Qiu Y, Zeng B, et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J Xray Sci Technol. 2020;28(3):383-389. DOI: 10.3233/XST-200685 32. Yu M, Liu Y, Xu D, Zhang R, Lan L, Xu H. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Dis- charged after Treatment for COVID-19 Pneumonia. Ko- rean J Radiol. 2020 Jun;21(6):746-755. DOI: 10.3348/ kjr.2020.0215 33. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Ab- normal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun 18;55(6):2001217. DOI: 10.1183/13993003.01217-2020 34. Santiago Pérez MI, López-Vizcaíno E, Ruano-Ravina A, Pérez-Ríos M. A Proposed Epidemiologic Risk Threshold for SARS-CoV-2 for Assisting Healthcare Decision-Ma- king. Arch Bronconeumol. 2021 Apr;57 Suppl 2:21-27. English, Spanish. DOI: 10.1016/j.arbres.2020.12.036 35. Tang S, Mao Y, Jones RM, et al. Aerosol transmission of SARS-CoV-2? Evidence, prevention and control. En- viron Int. 2020 Nov;144:106039. DOI: 10.1016/j.en- vint.2020.106039 36. Peña Otero D, Eguillor Mutiloa M. Medidas de protección individual y colectiva en la Covid-19. Rev Patol Respir., 23 (2020), pp. S268-S271. 37. Aranaz Andrés JM, Gea Velázquez de Castro MT, J. Vi- cente-Guijarro J, et al. Mascarillas como equipo de pro- tección individual durante la pandemia de COVID-19: cómo, cuándo y cuáles deben utilizarse. J Healthc Qual Res. 2020 Jul-Aug;35(4):245-252. Spanish. DOI: 10.1016/j.jhqr.2020.06.001 38. Moreno-Casbas MT. Grupo SANICOVI y Grupo de pro- fesionales de la salud trabajando en la pandemia CO- VID-19. Factores relacionados con el contagio por SARS-CoV-2 en profesionales de la salud en España. Proyecto SANICOVI. Enferm Clin (Engl Ed). 2020 Nov- Dec;30(6):360-370. English, Spanish. DOI: 10.1016/j.en- fcli.2020.05.021 39. Recomendaciones sobre prevencion de contagio por coronavirus en unidades de Funcion Pulmonar de los diferentes ambitos asistenciales. Area de Enfermeria de SEPAR, Asociacion de Enfermeria Comunitaria (AEC), Asociacion de Especialistas en Enfermeria del Trabajo (AET) y Sociedad Espanola de Alergologia e Inmunolo- giaClinica (SEAIC). En: https://drive.google.com/file/ d/ 1JPyCJ0_qiewcUTybJd0sxkruj-lbr8Z9/view 40. Cordovilla R, Álvarez S, Llanos L et al. SEPAR and AEER consensus recommendations on the Use of Bronchos- copy and Airway Sampling in Patients with Suspec- ted or Confirmed COVID-19 Infection. Arch Bronco- neumol. 2020; 56 Suppl 2: 19-26. DOI: 10.1016/j.ar- bres.2020.03.017 41. Pérez Pallarés J, Flandes Aldeyturriaga J, Cases Vied- ma E et al. SEPAR-AEER Consensus Recommenda- tions on the Usefulness of the Thoracic Ultrasound in the Management of the Patient with Suspected or Confirmed Infection with COVID-19. Arch Bronco- neumol. 2020; 56 Suppl 2: 27-30. DOI: 10.1016/j.ar- bres.2020.03.019

RkJQdWJsaXNoZXIy ODI4MTE=